Stephen Lim - Concepedia

Author

Stephen Lim

Cedars-Sinai Medical Center

Also Known As

S. Lim, S.W. Lim, STEPHEN W. LIM, Siew Ling Yvonne Lim, Stephen Lim, Stephen W Lim, Stephen W. Lim, Stephen Wong Lim

Publications

810

Citations

H-Index

Concepts

All Affiliations

Cedars-Sinai Medical Center Institute for Myeloma & Bone Cancer Research Novartis (United States)Oncotherapeutics (United States)Novartis (India)

About

Stephen Lim is an author at Cedars-Sinai Medical Center specializing in medicine, oncology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	376
2	Health Sciences	1	1	11
3	Natural Sciences	1	1	18
4	Biochemistry	1	1	18
5	Blood Transplantation	1	1	12

Stephen Lim

Publications

577

Citations

H-Index

Page 1

	Year	Citations
Temozolomide: a novel treatment for pituitary carcinoma Stephen Lim, Hrayr K. Shahinian, Menahem M. Maya, The Lancet Oncology MedicinePharmacotherapyPituitary DiseasePituitary CarcinomaOncology	2006	176
Kymriah® (tisagenlecleucel) – An overview of the clinical development journey of the first approved CAR-T therapy Rakesh Awasthi, Harald J. Maier, Jie Zhang, Human Vaccines & Immunotherapeutics Cell TherapyImmunologyPathologyTreatment ParadigmBiological Therapy	2023	83
Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors Odelia Cooper, Adam N. Mamelak, Serguei Bannykh, Endocrine Malignant DiseaseMedicinePathologyImmune Checkpoint InhibitorAnti-cancer Agent	2013	81
Rituximab as successful therapy in a patient with refractory paroxysmal cold hemoglobinuria Ahrin Koppel, Stephen Lim, Melanie Osby, Transfusion	2007	42
A Phase I Study of Ruxolitinib, Lenalidomide, and Steroids for Patients with Relapsed/Refractory Multiple Myeloma James R. Berenson, Jennifer To, Tanya M. Spektor, Clinical Cancer Research	2020	35
Cyclophosphamide, etoposide, vincristine, adriamycin, and dexamethasone (CEVAD) regimen in refractory multiple myeloma: An international oncology study group (IOSG) phase II protocol Francis J. Giles, Nicholas R. Wickham, Bernardo L. Rapoport, American Journal of Hematology	2000	23
Real-World Outcomes for Patients with Relapsed or Refractory (R/R) Aggressive B-Cell Non-Hodgkin's Lymphoma (aBNHL) Treated with Commercial Tisagenlecleucel: Subgroup Analyses from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry Daniel J. Landsburg, Matthew J. Frigault, Michael Heim, Blood	2022	22
Identification and characterization of regulatory elements of the human prostatic acid phosphatase promoter Stanislav Zelivianski, Tsukasa Igawa, Stephen Lim, Oncogene Signal TransductionProtein ExpressionBiochemistryNatural SciencesTranscription Regulation	2002	18
Mutation detection using plasma circulating tumor DNA (ctDNA) in a cohort of asymptomatic adults at increased risk for cancer. Anja Kammesheidt, Theresa R. Tonozzi, Stephen Lim, PubMed	2018	14
Alopecia areata as a paraneoplastic syndrome of Hodgkin’s lymphoma: A case report Jun Gong, Stephen Lim Molecular and Clinical Oncology Paraneoplastic SyndromeLymphoid NeoplasiaAutoimmune DiseaseSurgical PathologyPathology	2014	13

Page 1